A Centers for Medicare & Medicaid Services (CMS) proposal would remove a number of prescription drug classes from Medicare Part D drug plans, while also limiting the number of plans insurers could offer to seniors.
A Centers for Medicare & Medicaid Services (CMS) proposal would remove a number of prescription drug classes from Medicare Part D drug plans, while also limiting the number of plans insurers could offer to seniors. Although current Part D plans cover a variety of medications in 6 “protected” classes, CMS’s proposal would cut at least 2 of those protected classes in 2014, and potentially another in 2015. Those set for removal include prescription antidepressants, immunosuppressants, and antipsychotics. Many advocate groups worry that the proposal would limit patients’ access to the medications they’ve always had through their traditional Part D plans.
“The CMS administrators have said, ‘We don’t have any problems with the other drugs that aren’t in these protective classes,’ as they call them,” said Emily Ethridge of CQ Roll Call. “There are about 140 classes of drugs that Medicare has on its formulary plan. And there are only 6 that are in the ‘special’ categories. They’re saying ‘If you don’t have a problem with the other 134, we shouldn’t have any problems with a couple of these.’”
CMS administrators further voice concern over the oversaturation of plans in the marketplace. This can confuse senior citizens who, when faced with too much information and too many choices, will simply stick with 1 plan and not seek alternative options. The thought is that narrower offerings will make it easier for seniors to make better decisions about their health coverage.
“We heard a lot from the CMS officials about price and the cost of Medicare Part D, which covers prescription drugs. It’s increasing much higher than the rest of Medicare. They say this proposed rule would actually save money over 10 years. And they say it would make things simpler for seniors,” Ms Ethridge adds. “The healthcare law is reducing that prescription drug doughnut hole, that coverage gap that we’ve all heard so much about. If that’s being made smaller, then we don’t need all these plans to fill that in—we don’t need all these choices, and we don’t need to spend money on all of these options. It’s just not necessary.”
Around the Web
How Proposed Part D Changes Are Playing On Capitol Hill [Kaiser Health News]
Trump Administration’s Message to Supreme Court Puts New Wrinkle in Braidwood Case
February 21st 2025The Trump administration argues that HHS Secretary Robert F. Kennedy Jr can overrule the US Preventive Services Task Force to determine the preventive services covered under the Affordable Care Act.
Read More
Varied Access: The Pharmacogenetic Testing Coverage Divide
February 18th 2025On this episode of Managed Care Cast, we speak with the author of a study published in the February 2025 issue of The American Journal of Managed Care® to uncover significant differences in coverage decisions for pharmacogenetic tests across major US health insurers.
Listen
5 Key Health Care Moments During President Trump's First Month Back in Office
February 21st 2025President Donald J. Trump pushed for significant health care changes during his first month back in office, through executive orders affecting managed care, drug pricing, and clinical trial diversity guidance.
Read More
Same-Day Breast Imaging Gaps Reveal Health Care Disparities
February 18th 2025For this retrospective study, the authors examined data on more than 3 million screening mammographies for more than 1 million female patients; of the screenings, 23.6% had abnormal results and only 6.7% were recommended for biopsy.
Read More